All Posts

What would happen to your laboratory operations if your Administrative Lab Director left tomorrow? Unexpected retirements, health emergencies, career moves, or organizational restructuring can create gaps that immediately affect daily operations, compliance standing, and strategic momentum. The Leadership Challenge The laboratory workforce is experiencing a generational transition. According to ASCLS, more than 60% of laboratory professionals are approaching retirement age, w

PAMA cuts are currently scheduled to resume January 31, 2026—but if history is any guide, another delay remains possible.   Congress has intervened six consecutive times to postpone PAMA reimbursement cuts since 2020. The bipartisan RESULTS Act , introduced in September 2025, would freeze Clinical Laboratory Fee Schedule rates at current 2025 levels and cancel pending cuts through 2028. Industry advocacy through the "Stop Lab Cuts" campaign continues to push for passage.   Ho

Your 2026 laboratory budget is approved. The capital projects are funded. The service expansions are green-lit.   Now comes the hard part: making it happen.   Strategic plans only deliver value when they move into execution. Yet many laboratories struggle to translate approved initiatives into operational results—not because the strategy was flawed, but because execution lacks structure, accountability, and consistent oversight.   Where Execution Breaks Down 📋 Undefined acco

OIG enforcement is intensifying, and laboratories remain a primary focus.   False Claims Act settlements and judgments exceeded $6.8 billion in fiscal year 2025 —a record year. Laboratory-specific enforcement continues at a steady pace, with recent settlements involving kickback schemes, medically unnecessary testing, and improper referral arrangements resulting in multi-million dollar penalties and program exclusions.   For publicly traded laboratory companies, the complianc

The Challenge of Pathology Workflow Complexity Pathology and histology laboratories operate within some of the most complex workflows in the diagnostic space. Tissue handling, staining protocols, pathologist oversight, and quality monitoring all rely on systems that must be efficient, standardized, and continuously monitored for quality and compliance. Yet many pathology operations struggle with: Inconsistent specimen processing across multiple sites creating quality variabi

The Challenge of Growing Through Acquisition Health systems and physician groups continue expanding through mergers and acquisitions, but laboratory operations often remain disconnected. Separate LIS systems, fragmented EMR integrations, inconsistent reference lab contracts, and non-standardized protocols create hidden costs and missed opportunities.   The labs that thrive post-acquisition are those that approach consolidation strategically—not as a cost-cutting exercise, but

As we head toward the end of 2025, now is the right time to evaluate your compliance posture and enter 2026 with confidence. The Critical Window for Compliance Assessment Laboratory leaders across all settings—hospital core/outreach labs, independent commercial laboratories, physician office labs, and pathology/histology operations—understand that year-end is more than closing financial's. It's the opportunity to assess compliance readiness before regulatory agencies schedule